Cybin (HELP) Change in Accured Expenses (2020 - 2025)

Cybin (HELP) posted quarterly Change in Accured Expenses of $2.8 million for Q4 2025, down 35.15% year-on-year from $4.3 million in Q4 2024, and up 336.44% on a QoQ basis from -$1.2 million in Q3 2025.

Cybin (HELP) Change in Accured Expenses (2020 - 2025) Analysis & Trends

Cybin (HELP) has reported Change in Accured Expenses for 6 consecutive years, with $2.8 million the latest figure, recorded in Q4 2025.

  • Quarterly Change in Accured Expenses fell 35.15% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.6 million (up 272.82% YoY) and the FY2023 annual result came in at -$855934.0, down 134.24% from the prior year.
  • Change in Accured Expenses grew to $2.8 million in Q4 2025 per HELP's latest filing, from -$1.2 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for HELP reached as high as $4.3 million in Q4 2024 and fell as low as -$5.7 million in Q4 2023.
  • A 5-year average of $120243.9 and a median of $210703.5 in 2021 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2021 — Change in Accured Expenses jumped 1329.3% — and 2024, when it sank 1620.53%.
  • Year by year, Change in Accured Expenses stood at $330027.8 in 2021, then sank by 214.51% to -$377928.6 in 2022, then sank by 1414.63% to -$5.7 million in 2023, then soared by 175.86% to $4.3 million in 2024, then tumbled by 35.15% to $2.8 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered $2.8 million, -$1.2 million, and -$347000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.13 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -16.82 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -16.74 Mn
10 Cybin 28.04 Mn 28.04 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.82 Mn
Dec 31, 2025 2.82 Mn
Sep 30, 2025 -1.19 Mn
Sep 30, 2025 -1.19 Mn
Jun 30, 2025 -347,000.00
Jun 30, 2025 -347,000.00
Dec 31, 2024 4.34 Mn
Dec 31, 2024 4.34 Mn
Sep 30, 2024 1.93 Mn
Sep 30, 2024 1.93 Mn
Jun 30, 2024 -3.80 Mn
Jun 30, 2024 -3.80 Mn
Dec 31, 2023 -5.72 Mn
Dec 31, 2023 -5.72 Mn
Sep 30, 2023 2.42 Mn
Sep 30, 2023 2.42 Mn
Jun 30, 2023 250,136.03
Jun 30, 2023 250,136.03
Feb 28, 2023 -170,709.66
Feb 28, 2023 -170,709.66